| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 157.13B | 154.56B | 159.58B | 169.94B | 170.54B | 146.29B |
| Gross Profit | 22.98B | 20.83B | 23.71B | 21.79B | 23.26B | 20.90B |
| EBITDA | 10.03B | 8.45B | 10.68B | 8.95B | 9.62B | 9.97B |
| Net Income | 2.10B | 3.06B | 2.36B | -968.00M | 2.19B | 4.07B |
Balance Sheet | ||||||
| Total Assets | 135.89B | 141.52B | 138.67B | 147.07B | 156.41B | 142.96B |
| Cash, Cash Equivalents and Short-Term Investments | 12.65B | 17.14B | 16.16B | 22.24B | 30.62B | 19.97B |
| Total Debt | 49.77B | 45.29B | 52.35B | 57.06B | 66.65B | 49.56B |
| Total Liabilities | 87.50B | 84.99B | 88.81B | 99.24B | 106.72B | 94.31B |
| Stockholders Equity | 41.38B | 48.68B | 42.64B | 41.15B | 43.48B | 42.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.60B | 1.35B | 2.81B | -5.33B | -4.39B |
| Operating Cash Flow | 0.00 | 10.08B | 6.01B | 6.48B | -2.78B | -1.92B |
| Investing Cash Flow | 0.00 | -726.00M | -5.17B | -3.97B | -1.44B | 1.97B |
| Financing Cash Flow | 0.00 | -8.70B | -6.54B | -11.61B | 14.79B | -3.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
71 Outperform | ¥180.09B | 27.66 | 5.06% | 1.80% | 1.69% | 71.95% | |
67 Neutral | ¥30.47B | 8.82 | ― | 4.13% | -3.15% | 29.33% | |
62 Neutral | ¥371.52B | 11.21 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥186.09B | 19.21 | 7.36% | 3.42% | -17.96% | -43.14% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% |